Protein tyrosine phosphatases (PTPs) play an important role in the regulation of cell growth and differentiation.
Introduction
The importance of protein tyrosine phosphorylation in growth, differentiation and cytoskeletal integrity has been well established over the past decade. Protein tyrosine phosphatases (PIPS), enzymes that hydrolyze phosphotyrosyl groups, were initially considered to play 'housekeeping' roles by returning the tyrosine phosphorylation state of target substrates back to basal levels. This overly simplistic view now seems to be incorrect, since a number of PTPs have been shown to regulate integral components of signal transduction pathways (for recent reviews, see 11",2*,3**1). PTPs have been implicated in tumor suppression 14,5,6',7-91, cytoskeletal reorganization llO*",ll*l, development and differentiation 112**,13,14**1, mitotic induction [15g,16,17*l, T-cell activation 118.1, and in growth factor 119'-21*,22-241, somatostatin 1251 and interferon [26",27*1 signaling pathways. This review will focus on recent advances in understanding the function of receptor-like PTP extracellular domains, as well as the role of specific 'zip code' domains that govern intracellular PTP subcellular localization.
Protein tyrosine phosphatase structural domains
PTPs can be separated into two major groups: transmembrane receptor-like PTPs (Fig. 11 , and intracellular PTPs (Fig. 2) . All PTPs possess at least one catalytic domain of approximately 250 amino acids which contains the 'active site' signature motif WV)HCXAGMCRWT)G (in the one-letter amino acid code, where X can be any amino acid) 13",28"1. Studies using chemical modiflcation and site-directed mutagenesis have established that the cysteinyl residue within this consensus motif is essential for phosphatase activity, forming a thiophosphate enzyme intermediate necessary for catalysis 1291. This catalytic domain is unique to PTPs, bearing little resemblance to the catalytic domains of serine/threonine protein phospahatases, alkaline protein phosphatases, or acid protein phosphatases.
The receptor-like PTPs ( Fig. 1 ) possess an extracellular domain, a single transmembrane domain, and usually two intracellular PTP catalytic domains. The first intracellular PTP domain generally accounts for the majority of catalytic activity, while the second domain is inactive or (in some cases) weakly active 130°1. The only transmembrane PTPs containing a single catalytic domain are human (H) PTPB and Drosophila (D) PTPlOD 131-331. Receptor-like PTPs can be further subdivided into five types on the basis of common features found in the extracellular domain [l"l. Type I is represented by the CD45 family, exhibiting multiple isoforms arising from differential splicing of sequences at the amino terminus 1341. Type II members (e.g. LAR, HPTPK, and HPTPl,t) contain tandem repeats of immunoglobulinlike and libronectin type III-like domains resembling neural cell adhesion molecules 135,36,37*1. Type III members bear multiple fibronectin type III-like repeats (e.g. DPTPlO and DPTP99A) [32, 33, 381 . HITPa and HPTP& represent type IV isoforms, possessing small glycosylated segments 131,391. Type V constituents include HPTP< and IWIPy, which exhibit amino-terminal carbonic anhydrase-like domains [40,41'1. Although the structural features of the receptor-like PTPs suggest that they may bind ligands, no 'ligand' interaction has yet been identified. However, the extracellular domain of a receptor-like PTP has recently been shown to mediate cell-cell aggregation via homophilic binding [42-,43- SH-MP2 El*1 and its homologs (Syp &%Pl, PTPlD [69"1, PTPZC [701, and SH-PTP31711) .--Evidence that these SH2-1'TPs~may play a role in signal transduction comes from the characterization of two developmental genes, Hcph 114**,721 and corkscrew (csw) 173"l. Mice homozygous for the recessive allelic mutation motheaten display severe hematopoietic abnormalities [14",721. These mutations were recently localized to the Hcph gene, which encodes the SHZ-containing 1"Il' hematopoietic cell protein phosphatase 1661. Abnormalities in this protein may lead to defective signaling in hematopoiesis. Further evidence for the role of SH2-PTI's in signal transduction is provided by the Drosophila gene csw. This gene encodes an SHZ-Ml' that functions in the terminal class signal transduction pathway essential for normal development of anterior and posterior segments of the Drosophila embryo 173"l. Genetic experiments suggest that csw interacts with polehole (the Drosophila homolog of c-raf, 1741 to transduce signals generated from the receptor PTK torso (a I'DGF receptor homolog) 1751. The csw protein has high sequence identity with SH-PTP2 and may share functional similarities as well 176'1.
The exact nature of the interaction of SHZcontaining IJTI's with PTKs to positively transduce signals is unclear, although several possible models have been suggested 176'1. One possibility is that the amino-terminal SH2 domain of the PTI' binds an activated growth factor receptor (GFR), allowing the second SH2 domain to bind other phosphotyrosyl proteins. In this way, the PTI' is acting to bring proteins to the GFR for further phosphorylation, or to participate in other protein-protein interactions. In an alternative model, SHZ-binding of I'TI's to GFRs may allow the PTI' to dephosphorylate nearby phosphotyrosyl-regulated proteins. For example, activation of the insulin receptor results in the association of Syp with tyrosine-phosphorylated insulin receptor substrate 1, a protein participating in the insulin receptor signaling pathway 177'1. In addition, the proximal I'TI' may dephosphorylate and inactivate GFRs, thus terminating signal transduction. It is important to realize, however, that these two models may not be mutually exclusive A third mechanism of SHZI'TP-mediated GFR signal transduction has been suggested by more recent results. In this model, the SH2 domains facilitate PTP-GFR interaction, whereupon the PTI' is subsequently tyrosine-phosphorylated. The phosphorylated MI' could then interact with other SHZ-containing proteins in signal transduction. In addition, tyrosine phosphorylation may increase 1'TI' catalytic activity, potentially increasing the dephosphorylation of downstream effector molecules. Both Syp and PTI'lD were shown to associate in vivo with activated I'DGF and EGF receptors [68*,69 ..1. Both 1'TI's failed to dephosphorylate the GFR, .but were themselves tyrosine-phosphorylated. I'hosphorylation of SH2-PTI's may be required for interaction with receptor tyrosine kinases and other signaling molecules 168',69",76',78'1. In the case of PTPID, phosphorylation is correlated with a small increase in I'TI' catalytic activity in vitro [69"1. These findings indicate that SH2-FTPs may interact with PTKs, not simply to inactivate the GFR, but rather to work in concert with the GFR to regulate the phosphorylation state of signal transduction effector molecules.
Nuclear-targeting domains
Recently, several I'TPs were shown to localize to the nucleus [46",79'1, which is intriguing given the suggested functional role of I'TI's in cell cycle regulation and gene transcription [15*,16,26",27*1. In the case of the Drosophila I'TI' Dl'TI'61F, alternative splicing can produce two different carboxy-terminal zip codes directing the PTI' to alternative locations 179'1. Expression of each alternatively spliced form in COS-1 cells indicated that the form possessing a highly basic 11 amino acid carboxyl terminus was directed to the nucleus. The other Dl'TI'61F species, containing a carboxy-terminal splice of 24 hydrophobic amino acids, was localized to a 'reticular' network and mitochondria-like organelles within the cell. The substrate specificities of the nuclear and membrane 1'TI's were indistinguishable, as expected, since they share the identical catalytic domain. This underlines the fact that subcellular location can define and restrict the substrate specificity of PTI'ases within the cell. Dual specificity tyrosine/serine protein phosphatases
The first member of the class of dual specificity PTPs was identified in vaccinia virus 1841. This phosphatase, VHl, is a small (20 kDa) soluble phosphatase (Fig. 2) that dephosphorylates both phosphotyrosineand phosphoserine-containing substrates. VHl-like phosphatases have also been identified in smallpox variola virus, several orthopoxviruses and baculovirus 1851. In mammals, several VHl-like phosphatases have been cloned and shown to be induced as immediate-early genes. The synthesis of human T-cell PAC-1 179'1, human CL100 1861 and the mouse homolog 3CH134 120'1 is induced by serum growth factors and oxidative or heat stress. In addition, a yeast VI-D-like phosphatase has been shown to be induced upon nitrogen starvation 1871.
Serum growth factors activate transmembrane protein tyrosine kinases 1881. Mitogen-activated protein kinase (MAP kinase) has been shown to be a major component of the signaling pathway involved in transducing the signal from activated I'TKs to downstream effector molecules 1891. MAP kinase (~42) is activated by phosphorylation on Thr183 and Tyr185 by MAP kinase kinase 1901. The dual specificity phosphatases appear to dephosphorylate activated MAP kinase. Transcription of 3CH134 VFD-like phosphatase is rapidly induced by mitogenic stimulation, and synthesis occurs within the first hour 120'1. 3CH134 dephosphorylates Thr183 and Tyr185 on activated MAP kinase both in vitro and in vivo 191**1. In serum-stimulated iibroblasts, the inactivation of MAI' kinase coincides with the new synthesis of 3CH134 [91**1. Expression of 3CH134 in COS cells blocks serum-stimulation of MAP kinase, while the expression of a catalytically inactive 3CH134 augments MAP kinase phosphorylation. In addition, inactive 3CH134 can be immunoprecipitated with phosphorylated MAP kinase demonstrating a physical interaction 191**1. These findings suggest that 3CH134 may be the physiological MAP kinase phosphate.
Conclusions
With the recent characterization of receptor-like I'TP homophilic interactions, investigators can begin to approach the problem of understanding how these catalysts regulate signal processing during cell-cell contact. In addition, the characterization of intracellular I'TP targeting domains will allow researchers to begin to determine how the substrate specificity of these enzymes is controlled. Characterization of targeting domains will also provide clues about PTP localization and function in the cellular landscape. $vnp Qtrant Blol 1993, 57:193-202 . This study%epons the identification of two tyrosine phosphorylatedFocal adhesion cytoskeletal components, ppl2SFak and paxillin, that are phosphorylated during extracellular matrix-mediated cellular adhesion. Tyrosine phosphorylation is implicated as an important step in the events that Unk cell-extracellular matrix intemctions to cytoskeletal organization.
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CREWS This paper reports the novel finding that the interferon-a signal tmnsduction cascade involves both a membrane PTP and a tyrosine kinase. In addition, a second PTP participates by dephosphorylating a transcription complex in the nucleus, thereby inactivating transcription. A repon demonstrating that growth regulation in yeast requires the proper Functioning of two protein phosphatases, one tyrosine-and one threonine/serine-specific protein phosphatase.
A review detailing the current understanding of the mechanism of catalysis For PTPs. The amino acid residues important For PTP structure and catalysis and the determinants of substmte specificity are summarized. This paper presents models of how SHZ-containing proteins participate in receptor tyrosine kin&se signaling pathways. A current list of SHZ-containing proteins and their functions is discussed.
